Trial Follow-up Co-ordinator

Together we can do great things. Be part of something bigger.

With roles from hospitality to research,?there’s?a career for everyone at the University of Edinburgh. We can offer opportunities for you to develop in your career and make a real difference in the communities around us while contributing to the world at large.?

We seek an energetic, organised, motivated Trial Co-ordinator for the LACunar Intervention Trial 3 (LACI-3) funded by NIHR. LACI-3 is the largest and only Phase 3 trial in small vessel (lacunar) stroke in the world. Small vessel stroke is a major cause of vascular cognitive impairment and currently there is no effective treatment.

The University of Edinburgh is a world-class organisation. We are a large University covering a wide range of activities. In Professional Services, we support the University’s research and teaching, offering many career and role specialisms.

As the Trial Co-Ordinator for the LACI-3 trial, you will be responsible for following up trial participants by phone and post, assessing cognitive function, recurrent stroke and activities of daily living amongst other factors. Your role will be crucial to ensure high-quality, complete and successful data collection for this high-profile trial.

You will work closely with the LACI-3 Chief Investigator, Trial Managers, and implementation teams at the Universities of Edinburgh and Nottingham, the Investigator Group and Site teams. You will also help the Trial Manager and Trial Team with other activities, as appropriate to the stage of LACI-3, such as site set up, organising investigator meetings, maintaining up to date accurate trial records, and preparing various reports on LACI-3’s progress.

You will hold a degree in nursing, a relevant science subject and have experience in clinical trials research. You will have excellent spoken and written communication skills, and data entry skills. You will have experience of conducting patient assessments and interviews by telephone. You will demonstrate flexibility so as to accommodate patient follow-ups in a timely fashion.

You will have up to date knowledge of research ethics and R&D principles, and of Good Clinical Practice with an up-to-date GCP certificate.

A career with us has a range of other benefits that can be tailored to your lifestyle: 

• Working within one of the world’s leading universities
• Interesting work
• Good salary/pay rates

This post is full-time (35 hours per week); however, we may consider part-time or flexible working patterns. The post is primarily office based, but we may consider requests for a mix of office and home (hybrid) working (on a non-contractual basis).

As a valued member of our team, you can expect: 

• A competitive salary. 
• An exciting, positive, creative, challenging and rewarding place to work. 
• To be part of a diverse and vibrant international community.
• Comprehensive Staff Benefits, including generous annual leave entitlement, a defined benefits pension scheme, a wide range of staff discounts, family-friendly initiatives, and flexible work options.

Championing equality, diversity, and inclusion

The University of Edinburgh holds a Silver Athena SWAN award in recognition of our commitment to advance gender equality in higher education. We are members of the Race Equality Charter, and we are also Stonewall Scotland Diversity Champions, actively promoting LGBT equality. 

Prior to any employment commencing with the University, you will be required to evidence your right to work in the UK. 

On this occasion the University will not consider applicants requiring sponsorship for this role. International workers will therefore only be able to take up this role if they can demonstrate an alternative right to work in the UK.

Key dates to note

The closing date for applications is 16 June 2026

Unless stated otherwise the closing time for applications is 11:59pm UK time. If you are applying outside the UK the closing time on our adverts automatically adjusts to your browsers local time zone. 

Interview dates to be confirmed.